首页> 美国卫生研究院文献>Vaccines >Application of HDR-CRISPR/Cas9 and Erythrocyte Binding for Rapid Generation of Recombinant Turkey Herpesvirus-Vectored Avian Influenza Virus Vaccines
【2h】

Application of HDR-CRISPR/Cas9 and Erythrocyte Binding for Rapid Generation of Recombinant Turkey Herpesvirus-Vectored Avian Influenza Virus Vaccines

机译:HDR-CRISPR / Cas9和红细胞结合在快速产生重组土耳其疱疹病毒载体禽流感病毒疫苗中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Avian influenza viruses (AIVs) are highly contagious and have caused huge economical loss to the poultry industry. AIV vaccines remain one of the most effective methods of controlling this disease. Turkey herpesvirus (HVT) is a commonly used live attenuated vaccine against Marek’s disease; it has also been used as a viral vector for recombinant AIV vaccine development. The clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 system is a gene editing tool which, in vaccinology, has facilitated the development of recombinant DNA viral-vectored vaccines. Here, we utilize homology-directed repair (HDR) for the generation of a HVT–H7N9 HA bivalent vaccine; a H7N9 HA expression cassette was inserted into the intergenic region between UL45 and UL46 of HVT. To optimize the selection efficiency of our bivalent vaccine, we combined CRISPR/Cas9 with erythrocyte binding to rapidly generate recombinant HVT–H7HA candidate vaccines.
机译:禽流感病毒(AIV)具有高度传染性,并给家禽业造成了巨大的经济损失。 AIV疫苗仍然是控制这种疾病的最有效方法之一。土耳其疱疹病毒(HVT)是对抗马立克氏病的常用减毒活疫苗;它也被用作重组AIV疫苗开发的病毒载体。簇状规则间隔的回文重复序列(CRISPR)/ Cas9系统是一种基因编辑工具,在疫苗学中,它促进了重组DNA病毒载体疫苗的开发。在这里,我们利用同源直接修复(HDR)产生HVT–H7N9 HA二价疫苗;将H7N9 HA表达盒插入HVT的UL45和UL46之间的基因间区域。为了优化我们的二价疫苗的选择效率,我们将CRISPR / Cas9与红细胞结合在一起以快速生成重组HVT–H7HA候选疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号